Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Recent Research
Lysine acetyltransferase (KAT) is an enzyme that catalyzes the transfer of acetyl groups from acetyl-CoA to the lysine ε-amino group on the protein substrate. KAT includes multiple families, and MYST (MOZ, Ybf2/Sas3, Sas2 and KAT5) is one of them. As an important member of the MYST family, KAT5 plays a vital role in gene transcriptional regulation, DNA damage response, cell cycle, autophagy, and tumorigenesis and metastasis. KAT5 contains an N-terminal chromatin domain and a C-terminal conserved MYST domain. Also included in the MYST domain is a Cys-Cys-His-His zinc finger structure with a nuclear receptor cassette (NR-box) at the C-terminus that interacts with nuclear receptors.
KAT5 is involved in the regulation of transcription factors
Some reports show that KAT5 is involved in the regulation of a variety of nuclear hormone receptors, such as androgen receptor, estrogen receptor, glucocorticoid receptor and retinoid related receptors. The androgen receptor (AR) is involved in the growth and development of the prostate, and KAT5 binds through its C-terminal NR-box Leu-XX-leu-leu (LXXLL) motif and nuclear receptor activation function-2 (AF-2) domain to activate the nuclear hormone receptor. KAT5 can also directly acetylate AR to enhance its transcriptional activity. Moreover, KAT5 also has effect on early adipocyte differentiation. PPARγ is mainly involved in adipocyte differentiation and plays an important role in lipid homeostasis and energy metabolism. KAT5 interacts with the AF1 domain of PPARγ to activate transcriptional activation and participate in the differentiation of early adipocytes.
C-myc is a member of the myc gene family. It plays an important role in regulating gene expression, promoting cell growth and apoptosis. KAT5 acts as a c-myc coactivator involved in gene transcription, it directly acetylates c-myc, increases its stability and transcriptional activity. The KAT5 complex can also be recruited to the chromosome by myc, causing acetylation of histone H3K9, H3K14, H3K18, H4K5, H4K12 and other lysine sites to enhance myc transcriptional activity. Furthermore, KAT5 also participates in the activation of atrial natriuretic promoter with serum response factor (SRF) and involves in the regulation of SRF-dependent expression of cardiovascular related genes.
In other aspects, KAT5 can act as a synergistic inhibitor of STAT3 by inhibiting the transcriptional activity of STAT3 by recruiting HDAC7, thus causing tumor cell growth arrest and apoptosis. KAT5 acts as a co-suppressor of the ZEB (Zinc finger E box binding protein) and binds to ZEB to inhibit gene transcription. In addition, KAT5 is also involved in the regulation of the NF-κB signaling pathway, and together with the β-catenin complex, synergistically regulates the expression of the tumor metastasis suppressor gene KAI1 (Figure 1).
Figure 1. Model of KAT5 involvement in gene transcription
KAT5 participates in DNA damage repair
When DNA double-strand breaks, the histone H2AX first phosphorylates and forms a focal point at the breakpoint, and then recruits DNA repair related proteins such as Mre11-Rad50-Nbs1 complex (MRN) and ATM. It was found that KAT5 is important for the phosphorylation and homologous recombination of H2AX. It interacts with the MRN complex and aggregates into the DNA double-stranded damage site. TRRAP plays a bridging role in the interaction between KAT5 and MRN. KAT5 plays a direct role in the ATM activation process. When DNA is damaged, the acetyltransferase activity of KAT5 is activated. Then,KAT5 binds to the FATC domain of ATM to form a KAT5-ATM complex, acetylates the K3016 site of ATM and activates it. In turn, it induces ATM auto phosphorylation and initiates a series of downstream repair reactions.
KAT5 is also involved in the normal supply of intracellular dNTPs during DNA repair. In the low concentration state of dNTP, Ribonucleic acid reductase (RNR) is recruited to the DNA double-stranded damage site is a KAT5-dependent process. In the UV damage reaction, KAT5 can also undergo auto acetylation, which can enhance the binding ability of KAT5 to the substrate and enhance the activity of acetyltransferase. Recent studies have found that zinc finger protein 668 acts as a DNA repair regulator that interacts with KAT5. The knockdown of zinc finger protein 668 reduces the interaction of KAT5 with H2AX and affects radiation-induced H2AX hyperacetylation, which in turn affects staining. The loose state of the DNA affects the recruitment of DNA damage site repair proteins and homologous recombination repair.
KAT5 in DNA damage cell cycle, apoptosis, autophagy, glucose metabolism and stem cell regulation
It has been shown that p53 plays an important role in the regulation of KAT5-mediated apoptosis and cell cycle arrest. After DNA damage, the K120 site of p53 is rapidly acetylated by KAT5, and acetylated p53 specifically aggregates on the proapoptotic gene BAX and PUMA promoters, activates gene transcription and induces apoptosis. K120 acetylation loss specifically inhibits p53-mediated transcription of the apoptotic genes BAX and PUMA. Programmed cell death factor PDCD5 enhances KAT5 acetyltransferase activity, induces acetylation of K120 at p53, and promotes apoptosis-related gene expression. Besides, ING5, a coactivator of KAT5, is involved in the acetylation of the K120 locus of p53, which forms a complex with KAT5 and p53 and is involved in p53-mediated apoptosis under DNA damage.
However, KAT5 is not completely dependent on p53 during the apoptotic reaction. The knockdown of KAT5 can directly affect the activation of caspase 3, JNK phosphorylation and ATR pathway in cells, so that p53 is involved in the occurrence and regulation of apoptosis. It has been shown that KAT5 is involved in the regulation of autophagy. In the absence of growth factors, AKT is inhibited, which in turn activates GSK3 and phosphorylates the S86 site of KAT5, promoting KAT5 acetylation of ULK1 and affecting autophagy.
In addition, KAT5 plays an important role in the development of breast cancer. Twist is an important transcriptional activator of epithelial-mesenchymal transition. KAT5 can acetylate Twist's K73/K76 locus to interact with BET family member BRD4 combines and further activates expression of WNT5a, inhibition of WNT5a can reduce the invasiveness of breast cancer cells and the formation of tumor spheres.
Glycogen synthase (GSK-3) has been shown to phosphorylate the serine at position 86 of KAT5, which affects the K120 acetylation and PUMA expression of p53 and affects p53-mediated apoptosis. In addition, there are many other proteins involved in the regulation of apoptosis mediated KAT5, FANCD2 when localized in the nucleus to induce apoptosis. When lethal dose causes DNA damage, KAT5 can interact with Axin, inhibit the binding of Pirh2 and Axin, and form Axin- KAT5-HIPK2-p53 complex, which promotes p53 activation and induces apoptosis. Moreover, PCK1 (phosphoenolpyruvate carboxykinase) is an important regulatory kinase of the gluconeogenesis pathway. Recent studies have confirmed that KAT5 can regulate its kinase activity by acetylating the K514 site of PCK1, and then regulate gluconeogenesis by regulating key rate-limiting enzymes. Furthermore, KAT5 can maintain its dryness by regulating the expression of certain genes in stem cells. Diploid gene knockout KAT5 mice die early in the embryo, demonstrating the important role of KAT5 in stem cell function mainten.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.